コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ethyltransferases (PRMTs) and is degraded by dimethylarginine dimethylaminohydrolase.
5 ed higher amounts of ADMA-degradation enzyme dimethylarginine dimethylaminohydrolase-1 (but similar a
6 h the FXR agonist GW4064, we have identified dimethylarginine dimethylaminohydrolase-1 (DDAH1) as an
8 verexpression of the ADMA-hydrolyzing enzyme dimethylarginine dimethylaminohydrolase-1 (DDAH1), we te
10 We further observed myocardial levels of dimethylarginine dimethylaminohydrolase-1 were increased
11 treatment led to proteolytic degradation of dimethylarginine dimethylaminohydrolase 2, which catabol
13 ic dimethylarginine [ADMA, via inhibition of dimethylarginine dimethylaminohydrolase (DDAH) activity]
14 minated largely through active metabolism by dimethylarginine dimethylaminohydrolase (DDAH) and thus
15 termine whether overexpression of the enzyme dimethylarginine dimethylaminohydrolase (DDAH) could enh
19 hesized that lowering ADMA concentrations by dimethylarginine dimethylaminohydrolase (DDAH) overexpre
22 The activity, but not the expression, of dimethylarginine dimethylaminohydrolase (DDAH) was reduc
23 ntitumor therapeutics, as have inhibitors of dimethylarginine dimethylaminohydrolase (DDAH), an enzym
24 a corresponding increase in the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzym
25 bstituted arginine-modifying enzymes such as dimethylarginine dimethylaminohydrolase (DDAH), arginine
26 sed to inhibit the catabolic enzyme of ADMA, dimethylarginine dimethylaminohydrolase (DDAH), but the
28 lled by two isoforms of its catabolic enzyme dimethylarginine dimethylaminohydrolase (DDAH), the dysr
29 was associated with the reduced activity of dimethylarginine dimethylaminohydrolase (DDAH), the enzy
30 vely metabolized by the intracellular enzyme dimethylarginine dimethylaminohydrolase (DDAH), which ca
31 endothelial cells (ECV304) and on the enzyme dimethylarginine dimethylaminohydrolase (DDAH), which de
32 inine is eliminated largely by the action of dimethylarginine dimethylaminohydrolase (DDAH), which ex
37 sociated with a reduction in the activity of dimethylarginine dimethylaminohydrolase (DDAH, the enzym
38 le of ADMA, and the enzymes metabolizing it, dimethylarginine dimethylaminohydrolases (DDAH) in the r
39 itric oxide synthase [eNOS], Rho-kinase, and dimethylarginine dimethylaminohydrolase [DDAH]) were ana
43 ysregulation of the ADMA-metabolizing enzyme dimethylarginine dimethylaminohydrolase I (DDAH I) plays
44 The enzyme dimethylargininase (also known as dimethylarginine dimethylaminohydrolase or DDAH; EC 3.5.
45 ne deiminase (PaAgDI), and N(omega),N(omega)-dimethylarginine dimethylaminohydrolase (PaDDAH) indicat
46 lowering of ADMA by recombinant recombinant dimethylarginine dimethylaminohydrolase (rDDAH)-1 improv
48 crease ADMA because they bind to and inhibit dimethylarginine dimethylaminohydrolase, the enzyme that
49 co-workers to operate in the related enzyme dimethylarginine dimethylaminohydrolase, was further exp